Position in ALKS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$338,552,627
+$120,719,893 QoQ
Shares Held
6,460,928
+4.9% QoQ
Ownership
3.85%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#7
of 421 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $2,242,873,379 across 49 Drug Manufacturers - Specialty & Generic names. ALKS ranks #3 (15.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
1,708,739 | $925,846,052 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
2,335,897 | $393,692,080 | |
| 3 | ALKS |
Alkermes plc.
This page
|
6,460,928 | $338,552,627 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
7,347,028 | $106,458,435 | |
| 5 | ZTS |
Zoetis Inc.
|
1,403,300 | $100,841,138 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,478,180 | $68,750,151 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
1,366,549 | $49,469,073 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
1,733,801 | $43,986,531 |
All Filings in ALKS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $338,552,627 | 6,460,928 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $217,832,734 | 6,160,428 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $186,571,423 | 6,668,028 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $188,775,840 | 6,292,528 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $166,228,677 | 5,810,160 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $189,496,100 | 5,738,828 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $157,568,217 | 5,478,728 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $151,734,657 | 5,421,031 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $132,160,327 | 5,483,831 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $159,365,177 | 5,887,151 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $167,808,053 | 6,049,317 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $171,309,524 | 6,116,013 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $161,708,726 | 5,166,413 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $139,227,957 | 4,938,913 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $147,491,124 | 5,644,513 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $124,068,003 | 5,556,113 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $158,560,641 | 5,322,613 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $128,077,422 | 4,868,013 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $111,902,580 | 4,810,945 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $146,319,824 | 4,744,482 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $129,431,590 | 5,278,613 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $113,303,782 | 6,065,513 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $138,760,489 | 6,955,413 | Shares | Sole | 2021-02-10 | |
| 2020-06-30 | $138,490,602 | 7,135,013 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $103,551,649 | 7,181,113 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||